These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 16785785)
1. Expression of CD138 (Syndecan-1) in renal cell carcinoma is reduced with increasing nuclear grade. Gökden N; Greene GF; Bayer-Garner IB; Spencer HJ; Sanderson RD; Gökden M Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):173-7. PubMed ID: 16785785 [TBL] [Abstract][Full Text] [Related]
2. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential. Tickoo SK; Amin MB; Linden MD; Zarbo RJ Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210 [TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of kidney injury molecule-1 in renal epithelial neoplasms]. Dong YC; Wu B; Wang JD; Rao Q; Ma HH; Zhang RS; Zhou HB; Lu ZF; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):35-9. PubMed ID: 20388397 [TBL] [Abstract][Full Text] [Related]
4. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570 [TBL] [Abstract][Full Text] [Related]
5. Expression of vitamin D3 receptor in kidney tumors. Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927 [TBL] [Abstract][Full Text] [Related]
6. Alpha-methyl CoA racemase expression in renal cell carcinomas. Molinié V; Balaton A; Rotman S; Mansouri D; De Pinieux I; Homsi T; Guillou L Hum Pathol; 2006 Jun; 37(6):698-703. PubMed ID: 16733210 [TBL] [Abstract][Full Text] [Related]
7. Nucleophosmin expression in renal cell carcinoma and oncocytoma. Sari A; Calli A; Altinboga AA; Pehlivan FS; Gorgel SN; Balci U; Ermete M; Dincel C; Cakalagaoglu F APMIS; 2012 Mar; 120(3):187-94. PubMed ID: 22339675 [TBL] [Abstract][Full Text] [Related]
8. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Pan CC; Chen PC; Chiang H Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361 [TBL] [Abstract][Full Text] [Related]
11. Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma. Kuroda N; Guo L; Toi M; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Shuin T; Enzan H Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):315-8. PubMed ID: 11759057 [TBL] [Abstract][Full Text] [Related]
12. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma. Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941 [TBL] [Abstract][Full Text] [Related]
13. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma. Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598 [TBL] [Abstract][Full Text] [Related]
14. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison. Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047 [TBL] [Abstract][Full Text] [Related]
15. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study. Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004 [TBL] [Abstract][Full Text] [Related]
16. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. Mete O; Kilicaslan I; Gulluoglu MG; Uysal V Virchows Arch; 2005 Dec; 447(6):938-46. PubMed ID: 16133362 [TBL] [Abstract][Full Text] [Related]
17. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Pan CC; Chen PC; Ho DM Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648 [TBL] [Abstract][Full Text] [Related]
18. Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential? Horstmann M; Geiger LM; Vogel U; Schmid H; Hennenlotter J; Kuehs U; Merseburger AS; Kruck S; Stenzl A; Bedke J World J Urol; 2012 Aug; 30(4):525-31. PubMed ID: 21928123 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical identification of intracytoplasmic lumens by cytokeratin typing may differentiate renal oncocytomas from chromophobe renal cell carcinomas. Kuroda N; Toi M; Yamamoto M; Miyazaki E; Hayashi Y; Hiroi M; Shuin T; Enzan H Histol Histopathol; 2004 Jan; 19(1):23-8. PubMed ID: 14702167 [TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study. Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]